Skip to the main content.
HUB of
Biotherapeutic
Intelligence™
Protein Production
Overview
 
Catalog Products
Online Store
See our latest upcoming event
Tell me moreto Events
 
Connect with IPA

Contact usto Contact
Follow us on LinkedInto LinkedIn

HUB of
Biotherapeutic
Intelligence™
See our latest upcoming event
Tell me moreto Events
 
Connect with IPA

Contact usto Contact
Follow us on LinkedInto LinkedIn

HUB of
Biotherapeutic
Intelligence™
Applications
Insights
See our latest upcoming event
Tell me moreto Events
 
Connect with IPA

Contact usto Contact
Follow us on LinkedInto LinkedIn

HUB of
Biotherapeutic
Intelligence™
See our latest upcoming event
Tell me moreto Events
 
Connect with IPA

Contact usto Contact
Follow us on LinkedInto LinkedIn

HUB of
Biotherapeutic
Intelligence™
See our latest upcoming event
Tell me moreto Events
 
Connect with IPA

Contact usto Contact
Follow us on LinkedInto LinkedIn

Ranked #1 CRO1

IPA by design

Experience leads the way into a new era of accessible solutions.

From experience comes knowledge. No other CRO can offer the depth, breadth and experience that comes with greater than 3,000 completed monoclonal programs, over 35 years. From knowledge comes the wisdom to know how to hone massive amounts of intelligence into meaningful information for biotherapeutic research.

Join us at the next event

BioTechX

Date: Oct 9-10 | 2024

Location: Basel

Therapeutic

Modern therapeutic discovery campaigns must not only address the needs of our partners indications and modes of action, but also produce clinical lead candidates that are compatible and developable within the constraints of next generation scaffolds or payloads. IPA can create, characterize, engineer, and profile large panels of sequence and functionally diverse monoclonal antibodies. In addition, IPA has embedded in silico technology into its multi-species, multi-immunization, multi-platform approach to create an unmatched platform for discovery options and program designs.

Contact Us

Therapeutic Companion

There is more to a blockbuster drug than the drug itself. Much like the large and diverse teams that work together to bring today's therapeutics to market, therapeutic companion antibodies are integral components of the drug discovery process, with distinct roles and specifications. Whether anti-idiotypic, IHC, surrogate, or validation tools are required, IPA has the appropriate species and platform to get the job done right, the first time.

Contact Us

Diagnostics

IPA has a long and trusted history of providing diagnostic partners with the highly specific, antibody or antibody pairs their assays require. We are preferred partners in discovering and manufacturing antibodies for immunohistochemistry, point-of-care lateral flow assays, in vitro clinical diagnostics (IVD), mass spectrometry based IVD, western blots and ELISA assays. From biomarkers to small molecules, IPA is highly skilled in producing antibodies with the required traits: no-cross-reactivity, low background, and enhanced detection.

Contact Us

Protein Manufacturing

Mammalian protein expression and purification services tailored to your needs. Expression and production workflows are designed to deliver recombinant proteins and antibodies for research and pre-clinical applications. Antibodies can be manufactured from a transient expression system, from stable cell lines or from hybridoma culture or animal sera.

Contact Us

1. ROOTS 2022: Antibody Discovery Services and Platforms Market (4th Edition), 2021-2035; p.118